The conundrum of hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines

Radiotherapy and Oncology

Volumn 88, Issue 2, 2008, Pages 202-210

  Girinsky, Theodore ^a   Specht, Lena ^b   Ghalibafian, Mithra ^a   Edeline, Veronique ^c   Bonniaud, Guillaume ^a   Der Maazen, Richard Van ^d   Aleman, Berthe ^e   Paumier, Amaury ^a   Meijnders, Paul ^d   Lievens, Yolande ^f   Noordijk, Evert ^g   Poortmans, Philip ^h  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b FINSEN LABORATORY   (Denmark)

^c CENTRE RENÉ HUGUENIN   (France)

^d Institut Gustave Roussy ^*  (Belgium)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

^f Radiotherapy Department   (Belgium)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

Author keywords

EORTC GELA guidelines; Hodgkin lymphoma; Involved lymph nodes; Involved node radiotherapy

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; HODGKIN DISEASE; HUMAN; LYMPH NODE; PATIENT POSITIONING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION FIELD; SIMULATION; TREATMENT PLANNING;

CONTRAST MEDIA; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; PRACTICE GUIDELINES AS TOPIC; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 49349093004     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.05.012     Document Type: Article

References (11)

1. Girinsky T., van der Maazen R., Specht L., et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother Oncol 79 (2006) 270-277
2. Lister T.A., Crowther D., Sutcliffe S.B., et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease. J Clin Oncol 7 (1989) 1630-1636
3. Cheson B.D., Horning S.J., Coiffier B., et al. Report of an International Workshop to standardize response criteria for non-hodgkins lymphoma. J Clin Oncol 17 (1999) 1244-1253
4. Cheson B.D., Pfistner B., Juweid M.E., et al. Revised response criteria for malignant lymphoma. J Clin Oncol 25 (2007) 579-586
5. Guermazi A. Is it wise to eliminate lymphography from the staging of Hodgkin's disease?. Leuk Lymphoma 42 (2001) 655-660
6. Hanna S.L., Fletcher B.D., Boulden T.F., et al. MR imaging of infradiaphragmatic lymphadenopathy in children and adolescents with Hodgkin disease: comparison with lymphography and CT. JMRI 3 (1993) 461-470
7. Castellino R.A., Hoppe R.T., Blank N., et al. Computed tomography, lymphography and staging laparotomy: correlations in initial staging of Hodgkin disease. AJR 14 (1984) 37-41
8. Fletcher B.D., Glicksman A.S., and Gieser P. Interobserver variability in the detection of cervical-thoracic Hodgkin's disease by computed tomography. J Clin Oncol 17 (1999) 2153-2159
9. Valette F., Querellou S., Oudoux A., et al. Comparison of positron emission tomography and lymphangiography in the diagnosis of infradiaphragmatic Hodgkin's disease. Acta Radiol 48 (2007) 59-63
10. Girinsky T., Ghalibafian M., Bonniaud G., et al. Is FDG-Pet scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?. Radiother Oncol 85 (2007) 178-186
11. Specht L. 2-[18] Fluoro-2-deoxyglucose positron-emission tomography in staging, response, evaluation, and treatment planning of lymphomas. Sem Rad Oncol 17 (2007) 190-197